Amino acid replacement: V1003E.
T8832447A
V1001E | sns-PA; V1001E | sns-PB; V1001E | sns-PC
V1003E
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
Homozygous embryos show defects in myoblast fusion.
A small number of homozygotes survive to pupal development.
The garland cell nephrocytes of mutant third instar larvae have shape defects and are more loosely associated than normal.
The nephrocyte diaphragms in the garland cell nephrocytes of mutant second instar larvae are abnormal in structure when analysed by TEM.
Garland cell nephrocytes from mutant second instar larvae show reduced uptake of Alexa Fluor 555 BSA but not of dextran 10kD compared to controls after co-incubation with both tracers for 30 seconds.
Garland cell nephrocytes from mutant second instar larvae show efficient uptake of dextran 10kD after co-incubation with both Cascade Blue dextran 10kD and fluorescein dextran 500kD for 5 minutes. However, these cells show a very poor uptake of dextran 500kD under these conditions compared to controls.
sns4.3 has embryonic myoblast phenotype, enhanceable by dock[+]/dock04723
sns4.3 has embryonic myoblast phenotype, enhanceable by dock04723/dock04723